- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 495/02 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
Patent holdings for IPC class C07D 495/02
Total number of patents in this class: 117
10-year publication summary
|
5
|
5
|
5
|
5
|
4
|
3
|
7
|
2
|
9
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rohm and Haas Electronic Materials Korea Ltd. | 332 |
8 |
| Cephalon LLC | 121 |
6 |
| Korea Institute of Science and Technology | 2252 |
4 |
| Merck Patent GmbH | 5742 |
3 |
| Alantos Pharmaceuticals Holding, Inc. | 11 |
3 |
| Sunovion Pharmaceuticals Inc. | 244 |
3 |
| Tolremo Therapeutics AG | 25 |
3 |
| BASF SE | 21328 |
2 |
| Sumitomo Chemical Company, Limited | 8967 |
2 |
| Dana-Farber Cancer Institute, Inc. | 2671 |
2 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1614 |
2 |
| Enanta Pharmaceuticals, Inc. | 426 |
2 |
| Foghorn Therapeutics Inc. | 145 |
2 |
| Hanmi Holdings Co., Ltd | 20 |
2 |
| Kura Oncology, Inc. | 134 |
2 |
| Neurocrine Biosciences, Inc. | 464 |
2 |
| PGI Drug Discovery LLC | 32 |
2 |
| The Scripps Research Institute | 1345 |
2 |
| Shanghai Jingxin Biomedical Co., Ltd. | 26 |
2 |
| Zhejiang Jingxin Pharmaceutical Co., Ltd. | 33 |
2 |
| Other owners | 61 |